Skip to main content
Canadian Respiratory Journal logoLink to Canadian Respiratory Journal
. 2015 Sep-Oct;22(5):266–270. doi: 10.1155/2015/731357

Empowering family physicians to impart proper inhaler teaching to patients with chronic obstructive pulmonary disease and asthma

Janice M Leung 1, Mohit Bhutani 2, Richard Leigh 3, Dan Pelletier 4, Cathy Good 5, Don D Sin 1,6,
PMCID: PMC4596648  PMID: 26436910

Treatment of many chronic diseases involves oral drug ingestion or infusion. Chronic obstructive pulmonary disease and asthma, however, generally rely on inhaler devices to deliver medications and, are therefore, prone to critical errors in how they are used, which reduces their effectiveness. Given the significant economic and health burdens of chronic obstructive pulmonary disease and asthma in Canada, improved inhaler technique would lead to reduced number of emergency room visits and hospitalizations, and better clinical outcomes and disease control. This study aimed to determine whether a simple inhaler education program could influence physicians’ attitudes toward inhaler teaching in primary care practice, which is currently lacking.

Keywords: Asthma, COPD, Inhaler devices, Medical education, Primary care

Abstract

BACKGROUND:

Patients with chronic obstructive pulmonary disease (COPD) and asthma depend on inhalers for management, but critical errors committed during inhaler use can limit drug effectiveness. Outpatient education in inhaler technique remains inconsistent due to limited resources and inadequate provider knowledge.

OBJECTIVE:

To determine whether a simple, two-session inhaler education program can improve physician attitudes toward inhaler teaching in primary care practice.

METHODS:

An inhaler education program with small-group hands-on device training was instituted for family physicians (FP) in British Columbia and Alberta. Sessions were spaced one to three months apart. All critical errors were corrected in the first session. Questionnaires surveying current inhaler teaching practices and attitudes toward inhaler teaching were distributed to physicians before and after the program.

RESULTS:

Forty-one (60%) of a total 68 participating FPs completed both before and after program questionnaires. Before the program, only 20 (49%) reported providing some form of inhaler teaching in their practices, and only four (10%) felt fully competent to teach patients inhaler technique. After the program, 40 (98%) rated their inhaler teaching as good to excellent. Thirty-four (83%) reported providing inhaler teaching in their practices, either by themselves or by an allied health care professional they had personally trained. All stated they could teach inhaler technique within 5 min. Observation of FPs during the second session by certified respiratory educators found that none made critical errors and all had excellent technique.

CONCLUSION:

A physician inhaler education program can improve attitudes toward inhaler teaching and facilitate implementation in clinical practices.


Chronic obstructive pulmonary disease (COPD) and asthma currently affect approximately four million Canadians (1), causing an enormous burden to health care systems (2,3). Unlike other chronic diseases in which drugs can simply be ingested or infused, the management of COPD and asthma relies heavily on the use of inhaler devices to deliver medications, devices that require proper technique on the part of the patient for effective drug delivery. However, numerous studies have shown that patients often lack these necessary skills, committing critical errors that could limit overall drug effectiveness (46). The consequences of improper inhaler technique can be profound. The use of systemic steroids and antibiotics, not to mention rates of hospitalization and emergency room visits, is increased in those COPD and asthma patients found to commit at least one critical error when using their inhaler devices (7). Moreover, improper use can lead to significant oropharyngeal rather than pulmonary deposition of drug, thereby increasing the chances that patients will suffer side effects with reduced clinical benefit.

Educating patients regarding proper inhaler use has been shown to not only improve their technique, but also their clinical outcomes (810). Implementation of inhaler education into clinical practices is challenging. Few physicians and allied health care professionals provide inhaler education on a regular basis, with time constraints cited as a major reason (11,12). More disconcerting is the fact that health care providers themselves often exhibit poor technique when asked to demonstrate inhaler device use (12,13), raising questions as to their ability to teach patients even if they had the time to do it. In the present study, we implemented a two-session education program for family physicians with small-group hands-on inhaler device teaching aimed at improving patient inhaler use. Physician attitudes before and after the program were assessed via questionnaire surveys to determine the impact of the program on comfort with and implementation of inhaler device teaching in clinical practices.

METHODS

Inhaler education program

An inhaler education program targeted at family physicians (FPs) was instituted at three different Canadian locations (Vancouver [British Columbia], and Calgary and Edmonton [Alberta]) between April 2013 and June 2014. Physicians enrolled in the Vancouver program were drawn from around British Columbia, while physicians enrolled in the Calgary and Edmonton programs were drawn locally. The program consisted of two separate sessions spaced one to three months apart (depending on participating physician availability) with the aim of providing didactic repetition (14). The first session provided didactic teaching in the principles of drug particle delivery to the lungs as well as hands-on technical teaching for metered dose inhalers (MDIs) (with and without spacer devices) and dry powder inhalers (DPIs) (Turbuhaler, AstraZeneca Canada Inc; Diskus, GlaxoSmithKline Inc, Canada; Handihaler, Boehringer Ingelheim, USA; Twisthaler, Merck Canada Inc; and Breezhaler, Novartis Pharmaceuticals Canada Inc) by certified respiratory educators (CREs). Checklists of step-by-step instructions for proper MDI and DPI use, distributed by the Canadian Lung Association, were employed to ensure adequate performance (these are provided in the Supplemental Figure S1 [go to www.pulsus.com]). FPs were then instructed to apply these lessons to their practice in the interim between the first and second sessions. The second session reviewed the principles of the first session with reiteration of the hands-on inhaler technique teaching and their techniques were observed and rated by CREs. Slide decks and access to placebo inhalers were also provided to the physicians with the aim for physicians to not only teach patients proper inhaler technique, but also to disseminate these lessons among other physicians and allied health care professionals in their primary care practices and their communities.

Physician questionnaires

Before the first session, FPs enrolled in the program were asked to complete a questionnaire regarding their current practice habits on inhaler teaching. This survey is reproduced in its original form in Appendix 1. Three to six months after the end of the second session, physicians were then contacted again to complete a second electronic questionnaire (SurveyMonkey, USA) regarding the impact of the program on their inhaler teaching practices. This second survey is reproduced in its original form in Appendix 2. Physicians were allowed to remain anonymous when completing both questionnaires.

Statistics

The program coordinator collated results from the two questionnaires. Summary descriptive statistics were performed in Excel (Microsoft Corporation, USA) and in JMP version 10.0.2 (SAS Institute, USA).

Ethics and informed consent

Participating physicians were notified of the use of their answers for research purposes and consented to this provision before completion of the questionnaires.

RESULTS

Participant demographics

Characteristics of participating physicians are summarized in Table 1. Of a total of 68 participating physicians (23 from British Columbia, 25 from Edmonton and 20 from Calgary), 41 (60%) completed both preand post-education session surveys (18 [44%] from British Columbia, 17 [41%] from Edmonton and six [15%] from Calgary). Results are reported for these 41 physicians. The majority of physicians (77%) had practiced for >15 years. Five (13%) reported seeing between one and 10 asthma or COPD patients per week, 23 (59%) between 10 and 20, and 11 (28%) >20. Only 24 (59%) physicians had ever received prior hands-on education in how to use inhalers (of those who further described where this education was provided, eight reported receiving this education during medical school, one from a pharmaceutical company representative and six through continuing medical education programs). At the first session, all of the participating FPs made critical errors in the use of inhalers (eg, unable to open cap and poor breath holding), as noted by the CREs conducting the small group hands-on training sessions. However, all of these errors were remedied during this session. At the second face-to-face session, CREs observed each of the participating physician’s ability to use the inhaler devices and rated their performance as excellent.

TABLE 1.

Pre-education session evaluation

Question Response, n=41
Years in practice*
  1–5 1 (2.5)
  5–10 3 (7.5)
  10–15 5 (12.5)
  >15 31 (77.5)
Location
  British Columbia 18 (43.9)
  Edmonton, Alberta 17 (41.5)
  Calgary, Alberta 6 (14.6)
Number of asthma/COPD patients per week
  1–10 5 (12.8)
  10–20 23 (59.0)
  >20 11 (28.2)
Received prior hands-on education in inhaler use 24 (58.5)
Provides inhaler education to patients 20 (48.8)
  Metered dose inhalers, n/n 14/20
  Dry powder inhalers, n/n 19/20
  Spacer devices, n/n 13/20
  Inhaler care, n/n 7/20
Does not provide inhaler education 21 (51.2)
  Too busy, n/n 10/21
  Pharmacist, nurse or RT will take care of this, n/n 18/21
  Patients are typically good at using devices, n/n 1/21
Perceived competency in inhaler teaching
  Fully competent 4 (9.8)
  Somewhat competent 35 (85.4)
  Not competent 4 (9.8)

Data presented as n (%) unless otherwise indicated.

*

2 missing data points;

3 missing data points;

1 missing data point. COPD Chronic obstructive pulmonary disease; RT Respiratory technician

Pre-education session self-assessment of inhaler teaching

Before the inhaler education sessions, participating physicians were asked to evaluate the inhaler teaching currently provided to patients in their practices. These results are also shown in Table 1. Only 20 (49%) reported providing inhaler education to patients. Of these 20, 14 reported providing teaching on MDIs, 19 on DPIs and 13 on spacer devices. Only nine reported providing teaching on all three types of devices and seven reported teaching patients on inhaler care, including how to determine whether an inhaler is empty. For the 21 (51%) physicians who provided no inhaler teaching as part of their medical practice, 10 cited that they were too busy to provide this service and 14 believed that pharmacists were providing this teaching instead. One physician reported that patients were already competent at using inhaler devices. Overall, only four (10%) physicians felt fully competent at provider inhaler teaching for their patients. Thirty-five (85%) felt somewhat competent and four (10%) did not feel they were at all competent to teach patients on inhaler use.

Post-education session self-assessment of inhaler device teaching

Following completion of the inhaler device education program, FPs were asked to assess the change in the quality of their inhaler teaching to patients. Only 10 (24%) rated the quality of their inhaler device teaching before the program as either good or excellent. Six (15%) rated the quality of their inhaler device teaching as poor. After the program, however, the percentage of responders reporting good to excellent quality of inhaler teaching increased. Forty (98%) now rated their inhaler teaching as either good or excellent with no physicians reporting poor or fair quality teaching (Figure 1). Twenty-five (61%) reported now doing the majority of device teaching in their practices with another nine (22%) having trained support staff or other allied health care practitioners within their practices to provide inhaler teaching. Twenty-one (51%) stated that teaching inhaler device technique required 3 min to 5 min of a clinic visit, while 19 (46%) reported they could provide this teaching in ≤2 min. The most commonly reported subjective physician free-text comments on the inhaler education program are reported in Table 2. Twenty-two (54%) FPs reported witnessing improved efficacy of inhaler medications in their patients. Ten (24%) reported witnessing improved patient adherence and motivation, and 11 (27%) felt personal satisfaction that they were providing improved care as a primary care physician.

Figure 1).

Figure 1)

The quality of inhaler teaching provided to patients as self-assessed by physicians before (grey bars) and after (black bars) the inhaler education program. The percentage of responders reporting good to excellent quality of inhaler teaching increased following completion of the inhaler education program

TABLE 2.

Post-education session – perceived outcome statements*

Outcome Response, n=41
Perceived improvement in efficacy of drugs 22 (53.7)
Perceived improvement in patient compliance and motivation 10 (24.4)
Increased physician satisfaction in improving patient care 11 (26.8)
Improved patient satisfaction and knowledge 9 (21.4)
Increased physician confidence 7 (16.7)
Perceived minimized side effects 5 (11.9)

Data presented as n (%).

*

Free text comments were captured and categorized according to topic

DISCUSSION

For COPD and asthma, airways diseases for which no curative therapies currently exist, inhaler medications represent the mainstay of pharmacological treatment. Their complexity in design in terms of delivering medication to the airways, however, render inhaler devices dependent on patients employing proper technique for the drugs to work. Efforts to improve patient proficiency with inhalers are sadly lacking in primary care clinical practice. In the present study, we demonstrate that a physician education program specifically addressing pulmonary drug delivery principles (to elucidate why technique is important) and the practical aspects of inhaler use can alter the attitudes of FPs toward inhaler teaching and can facilitate its implementation in the outpatient primary care setting. Notably, physicians who had previously considered their knowledge on inhalers deficient now felt confident to report they were providing good to excellent inhaler teaching to their patients. As a result, more FPs were incorporating inhaler teaching into their practices, whether providing this service themselves or training other members of their staff to perform this teaching.

Importantly, the addition of inhaler teaching was not considered to be particularly burdensome from a time standpoint, because all participating FPs reported being able to teach inhaler technique in <5 min. Whether this allotted time is sufficient for adequate impartment of knowledge would be grounds for further study, as a previous report in the literature suggests that patients who were provided teaching in the 6 min to 10 min range made fewer errors than those whose teaching lasted between 1 min to 5 min (15). Key elements of our education program include direct observation of inhaler device technique by CREs and a multiple session format that takes advantage of learning repetition interspersed by practical application. The latter in particular has been shown to improve both short- and long-term retention in medical education (14). The use of a simple, step-by-step inhaler technique guide also enhanced our education program, because past investigations have found that patients do not always adequately learn proper inhaler technique simply from manufacturer instruction leaflets alone (16,17).

The findings of our study support the belief that inhaler device education in current primary care clinical practices is poorly implemented, either due to time or knowledge. Before our program, fewer than one-half of surveyed FPs reported providing some form of inhaler education to their patients, even fewer providing this service on the extensive range of devices now available for COPD and asthma patients (MDIs, DPIs and spacer devices). Surveys of COPD and asthma patients worldwide would echo these deficiencies. One survey of 450 asthma patients in Saudi Arabia suggested that just over 40% had never had any formal education on how to use inhalers (18), while 57% of COPD patients hospitalized for exacerbations in British Columbia reported having no inhaler education in the six months before their hospitalization (5). Even when inhaler education is implemented, the results are inconsistent. A survey of physicians in Quebec found that, on average, they taught only 30% of their COPD patients how to use their inhalers (19). Only 28% of over 1500 Spanish physicians surveyed reported checking their patients’ technique when prescribing a new inhaler (12).

While physicians may find that time constraints and a lack of appropriate placebo devices available for demonstration purposes effectively limit their abilities to impart proper inhaler technique (20), inadequacies in their own knowledge regarding these devices must also be considered a critical barrier. Before enrollment, very few physicians participating in our education program felt confident in their abilities to impart inhaler technique to their patients. Indeed, the results of formal testing of physicians on inhaler proficiency are often disappointing. The same survey of Spanish physicians revealed that only 14% had accurately identified the key steps to using MDIs and DPIs (one-quarter of physicians, for example, erroneously believed that DPIs required slow inspiratory flow rates) (12). Similarly, in a study testing MDI technique in pediatric residents, most were unable to correctly demonstrate the proper inspiratory and breath-holding maneuvers critical for successful use (21). Evaluations of pharmacists (2224) and nurses (25) appear suggest that these health care providers are no better in providing the correct teaching.

Given the current state of health care provider comfort on devices, it is perhaps not surprising that studies repeatedly show high error rates among patients using inhalers for COPD and asthma (6,26). Errors made by asthma patients when using the Diskus® and Turbuhaler® were found to mirror those made by the pharmacists training them, with particularly poor adherence with the exhalation and breath-holding steps in both groups (23). Needless to say, before significant improvement can be made in patients, first ensuring competence among providers is a necessary task. Once instructed, nearly all FPs enrolled in our program felt confident in their teaching abilities, rating the quality of their inhaler teaching as good to excellent, which was markedly improved from before. Although not formally assessed in the present study, the benefits of enhanced inhaler education have been demonstrated in multiple randomized controlled trials. Asthma patients assigned to formal inhaler education arms achieve greater improvements in asthma control scores (27), while COPD patients undergoing intensive training have fewer exacerbations, emergency room visits and hospitalizations compared with those without similar instruction (9,28).

There are several limitations to our study. First, as is common with most survey-based applications, we were only able to capture a portion of our target population. As a result, selection bias is a possibility and could influence the results of our study. Secondly, patient outcomes were not formally assessed so the impact of physician education on metrics of asthma and COPD control remains unclear. Finally, we acknowledge that primary care physicians are merely one aspect of an integrated health care system. Inhaler education provided by pharmacists and nurses, for example, plays an equally important role in respiratory health, but was beyond the purview of our study. Expansion of our education program to these allied health care professionals could further improve access to inhaler teaching, allowing it to occur in a multitude of health care settings.

In summary, we propose herein an education program directed at health care providers to improve the quality of inhaler device teaching in outpatient clinical practices. Aimed at addressing the many deficiencies in inhaler device proficiency within providers themselves, this program was able to improve physician confidence and comfort with inhaler devices, thus allowing more to institute inhaler education in their own practices. Proper use of inhaler medications is a cornerstone of COPD and asthma treatment and improved efforts at educating patients must be considered a priority for all health care providers.

APPENDIX 1. ASTHMA AND COPD INHALER DEVICE PROGRAM

Baseline Questionnaire:
Name (optional) __________________________________________
Years in practice:
  □ 1–5 □ 5–10 □ 10–15 □ >15
Appropriate number of asthma and/or COPD patients seen per week:
  □ 1–10 □ 10–20 □ >20
Have you received hands on education on inhaler device use?
  □ Yes □ No
  When and how was this taught (i.e. med school, CHE, one on one from an educator)? ______________________________________
Do YOU educate or check your own patient’s ability or technique on how to use their inhaler device appropriately and effectively?
  □ No Who does teach them? ________________________
  □ Yes, I do my own teaching. I teach appropriate us of the:
    □ Pressurized aerosol inhaler (pMDI)
    □ Dry powder inhalers (Diskus, Twisthaler, Turbuhaler)
    □ Space device
Does your education include how to tell if the device is empty and how to care for the device (cleaning, storing, etc...)?
  □ Yes □ No
If you do not educate patients on respiratory devices please indicate why (more than one answer is acceptable):
  □ Too busy to teach
  □ Pharmacist will take care of this
  □ Patients are typically good at using devices
  Other:□ _____________________________________________
Please indicate if you agree/disagree with the following statements:
  MDI’s (+/− spacer) are better than powder devices in patients with low inspiratory flow (ex. Elderly COPD patients)
  □ Agree □ Disagree
  With either a nebulizer, you know you’re getting the appropriate dose of medication every time.
  □ Agree □ Disagree
  Most patients know how to use their device as they have been using it for years – usually it’s only the newly diagnosed patients that need some coaching.
  □ Agree □ Disagree
Please indicate what you feel your level of competency is in educating your patients on how to use and care for their inhaler device
  □ Fully competent
  □ Somewhat competent
  □ Not competent
Other comments: __________________________________________

APPENDIX 2. POST PROGRAM DEVICE EDUCATION SURVEY

Insert baseline questions: Program attended, number of patients seen in a week, years of practice
Pre-program (circle your answer)
  Poor Fair Adequate Good Excellent
Post-program (circle your answer)
  Poor Fair Adequate Good Excellent
Prior to attending this program, I did the following for respiratory device education:
  □ I assumed patients were being trained by Allied Health Care Providers (ex. Pharmacist, RN, Nurse Practitioners, Certified Educators) and so I rarely educated on proper device technique
  □ I did the majority of the respiratory device education for my patients
  □ Other _____________________________________________
After attending this program, I have instituted device education in the following manner:
  □ I now do the majority of the respiratory device education for my patients
  □ Although I do not do the majority of device education, I have trained my support staff and AHCP’s to ensure it is done properly and on a consistent basis for most of my patients
  □ I see the need for device education, however, I simply don’t have enough, and so far, for most patients, I still assume Allied Health Care Providers in my community (ex. Pharmacist, RN, Nurse Practitioners, Certified Educators) will educate my patients on proper device technique
  □ Other _____________________________________________
When I ask the patient, “Show me how you use your device”, it usually takes ____ minutes to review their technique and make effective adjustments:
  □ 1 minute □ 2 minutes □ 3–5 minutes □ 10 minutes
  □ Other (enter the exact number of minutes it takes you in the comment box)
Which view point best describes yours:
  □ Device education should be given regardless of why a patient is seeing me – upon every visit
  □ Device education should only be given to new and existing respiratory disease patients on device technique who are seeing me for their respiratory condition
  □ Device education should only be given to patients with new prescriptions
Please list ideas/actions you have taken to ensure this education does not take up too much consult time ______________________________
List how you have changed your practice with respect to device education not mentioned above _____________________________________
Is there anything that you felt could have been added to the program? _ ______________________________________________________
List the most eye opening gem(s) you took away from this program: ______________________________________________________

Footnotes

FUNDING: Financial support for this educational program was provided by AstraZeneca Canada Inc.

DISCLOSURES: The authors have no finacial disclosures or conflicts of interest to declare.

REFERENCES

  • 1.Statistics Canada . Health Trends. Statistics Canada; Ottawa: 2014. Catalogue No. 82-213-XWE. Released June 12, 2014. < www12.statcan.gc.ca/health-sante/82-213/index.cfm?Lang=ENG> (Accessed December 18, 2014). [Google Scholar]
  • 2.Gershon AS, Guan J, Victor JC, Goldstein R, To T. Quantifying health services use for chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187:596–601. doi: 10.1164/rccm.201211-2044OC. [DOI] [PubMed] [Google Scholar]
  • 3.Ismaila AS, Sayani AP, Marin M, Su Z. Clinical, economic, and humanistic burden of asthma in Canada: a systematic review. BMC Pulm Med. 2013;13:70. doi: 10.1186/1471-2466-13-70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Bryant L, Bang C, Chew C, Baik SH, Wiseman D. Adequacy of inhaler technique used by people with asthma or chronic obstructive pulmonary disease. J Prim Health Care. 2013;5:191–8. [PubMed] [Google Scholar]
  • 5.Batterink J, Dahri K, Aulakh A, Rempel C. Evaluation of the use of inhaled medications by hospital inpatients with chronic obstructive pulmonary disease. Can J Hosp Pharm. 2012;65:111–8. doi: 10.4212/cjhp.v65i2.1118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Wieshammer S, Dreyhaupt J. Dry powder inhalers: Which factors determine the frequency of handling errors? Respiration. 2008;75:18–25. doi: 10.1159/000109374. [DOI] [PubMed] [Google Scholar]
  • 7.Melani AS, Bonavia M, Cilenti V, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med. 2011;105:930–8. doi: 10.1016/j.rmed.2011.01.005. [DOI] [PubMed] [Google Scholar]
  • 8.Basheti IA, Reddel HK, Armour CL, Bosnic-Anticevich SZ. Improved asthma outcomes with a simple inhaler technique intervention by community pharmacists. J Allergy Clin Immunol. 2007;119:1537–8. doi: 10.1016/j.jaci.2007.02.037. [DOI] [PubMed] [Google Scholar]
  • 9.Tommelein E, Mehuys E, Van Hees T, et al. Effectiveness of pharmaceutical care for patients with chronic obstructive pulmonary disease (PHARMACOP): A randomized controlled trial. Br J Clin Pharmacol. 2014;77:756–66. doi: 10.1111/bcp.12242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Yildiz F. Importance of inhaler device use status in the control of asthma in adults: The asthma inhaler treatment study. Respir Care. 2014;59:223–30. doi: 10.4187/respcare.02478. [DOI] [PubMed] [Google Scholar]
  • 11.Rene-Henri N, Khamla Y, Nadaira N, et al. Community pharmacists’ interventions in asthma care: A descriptive study. Ann Pharmacother. 2009;43:104–11. doi: 10.1345/aph.1L308. [DOI] [PubMed] [Google Scholar]
  • 12.Plaza V, Sanchis J, Roura P, et al. Physicians’ knowledge of inhaler devices and inhalation techniques remains poor in Spain. J Aerosol Med Pulm Drug Deliv. 2012;25:16–22. doi: 10.1089/jamp.2011.0895. [DOI] [PubMed] [Google Scholar]
  • 13.Basheti IA, Qunaibi EA, Hamadi SA, Reddel HK. Inhaler technique training and health-care professionals: Effective long-term solution for a current problem. Respir Care. 2014;59:1716–25. doi: 10.4187/respcare.02671. [DOI] [PubMed] [Google Scholar]
  • 14.Davis D, Galbraith R. Continuing medical education effect on practice performance: Effectiveness of continuing medical education: American College of Chest Physicians Evidence-Based Educational Guidelines. Chest. 2009;135:42s–48s. doi: 10.1378/chest.08-2517. [DOI] [PubMed] [Google Scholar]
  • 15.Sestini P, Cappiello V, Aliani M, et al. Prescription bias and factors associated with improper use of inhalers. J Aerosol Med. 2006;19:127–36. doi: 10.1089/jam.2006.19.127. [DOI] [PubMed] [Google Scholar]
  • 16.Melani AS, Zanchetta D, Barbato N, et al. Inhalation technique and variables associated with misuse of conventional metered-dose inhalers and newer dry powder inhalers in experienced adults. Allergy Asthma Clin Immunol. 2004;93:439–46. doi: 10.1016/s1081-1206(10)61410-x. [DOI] [PubMed] [Google Scholar]
  • 17.Ronmark E, Jögi R, Lindqvist A, et al. Correct use of three powder inhalers: Comparison between Diskus, Turbuhaler, and Easyhaler. J Asthma. 2005;42:173–8. [PubMed] [Google Scholar]
  • 18.Al-Jahdali H, Ahmed A, Al-Harbi A, et al. Improper inhaler technique is associated with poor asthma control and frequent emergency department visits. Allergy Asthma Clin Immunol. 2013;9:8. doi: 10.1186/1710-1492-9-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Boulet LP, Devlin H, O’Donnell DE. The Physicians’ Practice Assessment Questionnaire on asthma and COPD. Respir Med. 2011;105:8–14. doi: 10.1016/j.rmed.2010.07.022. [DOI] [PubMed] [Google Scholar]
  • 20.Reznik M, Jaramillo Y, Wylie-Rosett J. Demonstrating and assessing metered-dose inhaler-spacer technique: Pediatric care providers’ self-reported practices and perceived barriers. Clin Pediatr. 2014;53:270–6. doi: 10.1177/0009922813512521. [DOI] [PubMed] [Google Scholar]
  • 21.Amirav I, Goren A, Pawlowski NA. What do pediatricians in training know about the correct use of inhalers and spacer devices? J Allergy Clin Immunol. 1994;94:669–75. doi: 10.1016/0091-6749(94)90173-2. [DOI] [PubMed] [Google Scholar]
  • 22.Ali HD, Worku GS, Alemayehu AA, Gebrehiwot WH. Competence in metered dose inhaler technique among dispensers in Mekelle. Allergy Asthma Clin Immunol. 2014;10:18. doi: 10.1186/1710-1492-10-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Basheti IA, Qunaibi E, Bosnic-Anticevich SZ, et al. User error with Diskus and Turbuhaler by asthma patients and pharmacists in Jordan and Australia. Respir Care. 2011;56:1916–23. doi: 10.4187/respcare.01205. [DOI] [PubMed] [Google Scholar]
  • 24.Gemicioglu B, Borekci S, Can G. Investigation of knowledge of asthma and inhaler devices in pharmacy workers. J Asthma. 2014;51:982–8. doi: 10.3109/02770903.2014.928310. [DOI] [PubMed] [Google Scholar]
  • 25.De Tratto K, Gomez C, Ryan CJ, Bracken N, Steffen A, Corbridge SJ. Nurses’ knowledge of inhaler technique in the inpatient hospital setting. Clin Nurse Spec. 2014;28:156–60. doi: 10.1097/NUR.0000000000000047. [DOI] [PubMed] [Google Scholar]
  • 26.Ganguly A, Das AK, Roy A, Adhikari A, Banerjee J, Sen S. Study of proper use of inhalational devices by bronchial asthma or COPD patients attending a tertiary care hospital. J Clin Diagn Res. 2014;8:Hc04–07. doi: 10.7860/JCDR/2014/9457.4976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Garcia-Cardenas V, Sabater-Hernandez D, Kenny P, Martinez-Martinez F, Faus MJ, Benrimoj SI. Effect of a pharmacist intervention on asthma control. A cluster randomised trial. Respir Med. 2013;107:1346–55. doi: 10.1016/j.rmed.2013.05.014. [DOI] [PubMed] [Google Scholar]
  • 28.Goris S, Tasci S, Elmali F. The effects of training on inhaler technique and quality of life in patients with COPD. J Aerosol Med Pulm Drug Deliv. 2013;26:336–44. doi: 10.1089/jamp.2012.1017. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Respiratory Journal : Journal of the Canadian Thoracic Society are provided here courtesy of Wiley

RESOURCES